CNCR vs. PSIL ETF Comparison
Comparison of Loncar Cancer Immunotherapy ETF (CNCR) to AdvisorShares Psychedelics ETF (PSIL)
CNCR
Loncar Cancer Immunotherapy ETF
CNCR Description
ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.
Grade (RS Rating)
Last Trade
$14.63
Average Daily Volume
45,541
72
PSIL
AdvisorShares Psychedelics ETF
PSIL Description
AdvisorShares Trust - AdvisorShares Psychedelics ETF is an exchange traded fund launched and managed by AdvisorShares Investments, LLC. The fund invests in public equity markets of global region. It invests directly and through derivatives in stocks of companies operating across healthcare, pharmaceuticals, biotechnology and life sciences companies focused on plant-based psychedelic medicines as well as other companies with business activities in the psychedelics industry sectors. The fund uses derivatives such as swaps to create its portfolio. It invests in growth and value stocks of companies across diversified market capitalization. The investment seeks long-term capital appreciation. AdvisorShares Trust - AdvisorShares Psychedelics ETF is domiciled in the United States.Grade (RS Rating)
Last Trade
$1.28
Average Daily Volume
76,566
9
Performance
| Period | CNCR | PSIL |
|---|---|---|
| 30 Days | -8.88% | -13.82% |
| 60 Days | -10.72% | -10.27% |
| 90 Days | 9.80% | -5.07% |
| 12 Months | 15.63% | -29.05% |
0 Overlapping Holdings
| Symbol | Grade | Weight in CNCR | Weight in PSIL | Overlap |
|---|
CNCR Overweight 72 Positions Relative to PSIL
| Symbol | Grade | Weight | |
|---|---|---|---|
| GERN | A | 2.45% | |
| ELVN | B | 2.04% | |
| NUVB | B | 1.9% | |
| TSVT | D | 1.79% | |
| GLUE | C | 1.59% | |
| FHTX | C | 1.53% | |
| VOR | F | 1.53% | |
| STRO | F | 1.52% | |
| ACRV | A | 1.5% | |
| ITOS | D | 1.47% | |
| MGNX | C | 1.47% | |
| ERAS | D | 1.39% | |
| SDGR | F | 1.37% | |
| ACET | D | 1.37% | |
| PRLD | B | 1.36% | |
| DNA | F | 1.35% | |
| MRK | B | 1.35% | |
| BPMC | C | 1.34% | |
| IPHA | C | 1.33% | |
| EXEL | A | 1.33% | |
| ZNTL | D | 1.33% | |
| JANX | A | 1.32% | |
| IMCR | F | 1.3% | |
| SNDX | D | 1.3% | |
| KPTI | F | 1.3% | |
| MOR | A | 1.3% | |
| BCYC | D | 1.29% | |
| CGEM | C | 1.29% | |
| HCM | B | 1.29% | |
| LYEL | A | 1.28% | |
| INBX | D | 1.28% | |
| RVMD | A | 1.28% | |
| NRIX | B | 1.27% | |
| DAWN | C | 1.27% | |
| GMAB | C | 1.27% | |
| PGEN | D | 1.27% | |
| MRUS | D | 1.27% | |
| RAPT | F | 1.27% | |
| XNCR | F | 1.26% | |
| REGN | C | 1.26% | |
| AURA | F | 1.25% | |
| BMY | F | 1.25% | |
| BNTX | F | 1.24% | |
| YMAB | C | 1.24% | |
| TYRA | F | 1.24% | |
| AUTL | D | 1.23% | |
| IDYA | D | 1.21% | |
| DCPH | D | 1.21% | |
| KURA | D | 1.2% | |
| KYMR | D | 1.19% | |
| RCUS | F | 1.19% | |
| FATE | D | 1.19% | |
| IOVA | D | 1.18% | |
| SWTX | D | 1.15% | |
| IMTX | D | 1.15% | |
| ALLO | F | 1.14% | |
| RLAY | F | 1.13% | |
| ACLX | D | 1.12% | |
| IGMS | D | 1.11% | |
| ARVN | D | 1.08% | |
| LEGN | F | 1.07% | |
| MRSN | D | 1.07% | |
| SMMT | D | 1.07% | |
| RXRX | F | 1.07% | |
| CRBU | F | 1.05% | |
| REPL | F | 1.04% | |
| NUVL | D | 1.04% | |
| RPTX | F | 1.0% | |
| AGEN | F | 1.0% | |
| GNLX | F | 0.97% | |
| BMEA | F | 0.96% | |
| IMRX | F | 0.94% |
CNCR: Top Represented Industries & Keywords
PSIL: Top Represented Industries & Keywords
Compare ETFs
